Anders Kolb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An interview with Dr. E. Anders Kolb, president and CEO of the Leukemia & Lymphoma Society in Rye Brook.

/PRNewswire/ -- The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, is proud to announce E. Anders...

/PRNewswire/ -- The American Cancer Society and the St. Baldrick's Foundation awarded nearly $3 million to researchers fighting to end childhood cancer. The...

Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in Blood Advances, a journal of the American Society of Hematology. The study, co-authored by researchers with Nemours Children's Health System, outlines the process and potential path for new immunotherapy drugs that improve survival and reduce treatment-related toxicity in children with AML. Leukemia is the mo...